Stocks in Focus on August 21: United Spirits, IOL Chemicals to Alembic Pharma; Here are 5 Newsmakers of the Day

Reversing early gains, the key equity barometers ended with modest losses on Tuesday, August 20, 2019. However, certain stocks came in news after the markets were closed for trading purposes which can play an important role in driving the market on Wednesday. Here is a list of five such stocks:

United Spirits: Diageo group owned entity Relay BV on Tuesday purchased 33.1 lakh shares of United Spirits Ltd at a price of Rs591.95 per share, valuing the transaction at Rs195.96 crore. Relay BV is a promoter entity of United Spirits.

Dr Reddy’s: The US health regulator, US Food & Drug Administration (USFDA), has issued a Form 483 with 8 observations to Dr Reddy’s Laboratories after the inspection of its Duvvada facility in Andhra Pradesh. The audit of the company’s formulations manufacturing plant, Vizag SEZ Plant 1, at Duvvada, Visakhapatnam was completed on Tuesday.

IOL Chemicals & Pharmaceuticals Ltd: The company on Tuesday said that it has made the pre-payment of a term loan of Rs9.52 crore due to banks in addition to scheduled repayment. It has made the pre-payment of a term loan of an aggregate of Rs 107.70 Crore till date (i.e. Rs 87.65 Crore during the Current FY and Rs 20.05 Crore in Previous FY) to reduce the Term Debt, which remains at Rs 123.45 Crore as on date.

NMDC: The state-owned company NMDC on Tuesday said the Karnataka government has withdrawn the approval accorded to the firm to extend mining lease for the Donimalai iron ore mine. In this regard, the firm said that it has filed revision application against the Karnataka government’s order with the Ministry of Mines, Government of India, and the hearing is scheduled for Wednesday.

Watch Zee Business Live TV

Alembic Pharma: The US health regulator, USFDA gave a clean cheat to Alembic Pharmaceuticals' Bioequivalence Facility located at Vadodara. The facility was inspected by USFDA between August 12-16, 2019 and between August 12-20, 2019 for Bioequivalence Bioanalytical and Bioequivalence Clinical respectively.